Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

W
Wæhre T. - Interleukin-7-mediated inflammation in unstable angina – possible role of chemokines and platelets
Waaijenborg S. - Co-localization of c-AMP-dependent PKA with eNOS in endothelial cell junctions: a clue for regulated NO production
Wada H. - Frequency of biphasic transmittance waveform in the APTT coagulation assay in the patients with underlying diseases of DIC
Wada H. - Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
  - Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Wada H. W. - Usefulness of fully automated measurement of reticulated platelet using the whole blood
Waddy S. - Phospholipid-dependent impairment of the inhibitory properties of hirudin: the cause of false-positive assays for lupus anticoagulants (LAs)
Wadham P. - Thrombin potential in heparin induced thrombocytopenia
Wadsworth L. D. - An assessment of the appropriateness of published pediatric dosage guidelines for low molecular weight heparin (Enoxaparin) in a tertiary care institution
  - Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
  - Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Wagenvoord R. - The calibrated Thrombogram: exact monitoring of thrombin generation in clotting platelet rich- and platelet poor plasma
Wagenvoord R. - Exposure of procoagulant phospholipids in blood during exhaustive physical exercise
Waggie K. - Recombinant human Factor XIII decreases gut ischemia reperfusion injury in the rat
Wagner O. - Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
Wagner D. - Platelet interaction with stimulated or injured vessel wall
Wagner D. D. - Inhibition of metalloproteases during platelet storage leads to better platelet recovery and improved platelet function upon transfusion
Wagner D. - Anti-thrombotic effects of tumor necrosis factor-a
Wagner B. E. - An unusual case of acquired giant platelet syndrome with May Hegglin features and Hermansky-Pudlak-like platelets
Wagner O. - A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
Wahl D. - Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
Wahl D. - Increased thrombin potential due to acquired activated protein C resistance in patients with lupus anticoagulants
Wåhlander K. - Excretion of the oral direct thrombin inhibitor ximelagatran into breast milk following oral administration to breast-feeding women
Wahlander K. - Extended secondary prevention with the oral direct thrombin inhibitor ximelagatran for 18 months after 6 months of anticoagulation in patients with venous thromboembolism: a randomized, placebo-controlled trial
Wakabayashi H. - Copper binding site(s) in factor VIII involved in the regulation of cofactor specific activity
Wakefield C. D. - Development of the Canadian hemophilia outcomes – Kids Life Assessment Tool (CHO-KLAT)
Wakefield C. - Underlying platelet function disorders and von Willebrand disease in children with epistaxis or menorrhagia
Walcher W. - Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
Walenga J. - The irrelevance of International Normalized Ratio in the monitoring of anti-IIa and anti-Xa drugs
  - Interaction of thrombolytic agents with argatroban: pharmacological implications
Walenga J. M. - Influence of argatroban alone and combined with oral anticoagulants on the assessment of coagulation factors
Walenga J. M. - Activation of neutrophils by antibodies generated in heparin-induced thrombocytopenia
  - Platelet and inflammatory changes induced by angioplasty and brachytherapy
  - Reviparin normalizes tissue factor pathway activation in patients with lower limb immobilization and is not associated with heparin antibody production
  - Oral antithrombin agents comprise the regulatory functions of thrombin
  - Prevalence of anti-Erythropoietin antibodies in end stage renal disease patients treated with recombinant Erythropoietin
Walenga J. - Argatroban anticoagulation inhibits thrombin generation and its rebound during percutaneous interventional procedures
  - Lack dose-response with Fondaparinux and Idraparinux is due to endogenous antithrombin saturation
Walenga J. M. - Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
Walenga J. M. - A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
  - Transition of treatment with i.v. Argatroban to Phenprocoumon and Acencoumarol
  - Lower limb trauma is associated with a moderate risk of thrombosis caused by sustained release of tissue factor despite early functional mobilization
Walenga J. M. - Intimatan ameliorates the activation of human platelets by heparin/heparin antibody from patients with heparin-induced thrombocytopenia
Walenga J. M. - Activation of platelets by HIT antibodies in vitro is not dependent on the presence of heparin
  - Heparin-induced anti-platelet antibodies in very low birth-weight infants
Walford C. - A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
Walker I.D. - The effect of ABO and Secretor genotypes on thrombin generation
Walker I. - The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
Walker I. D. - Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population
Walker J. B. - The carboxypeptidase mediated down-regulation of fibrinolysis exhibits a threshold effect which is masked by the intrinsic instability of TAFIa
Walker I. D. - The G>T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia
  - The effect of low and high dose aspirin on the expression of monocyte tissue factor
Walker I. - Screening for thrombophilia: an economic assessment
Walker M. - Associations of hemostatic and inflammatory variables with prevalent myocardial infarction, angina and stroke in British men: British Regional Heart Study
Walker I. D. - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Walker I. - Patterns of factor prophylaxis in the Canadian hemophilia A population
  - Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
Walkowiak B. - Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Walkowiak B. - Phosphorylation of platelet proteins in hemodialysed patients is different than in control donors
Wallace I. W. - Population prevalence of atrial fibrillation and factors associated with use of warfarin
Wallace T. - Arterial thromboembolic disease in infants and children
  - Prospective cohort study of paediatric venous thrombosis
Wallace I. W. - Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
Wallaschofski H. - The molecular mechanisms of platelet activation by prolactin
Wallén N. H. - Clopidogrel treatment provides limited protection against exercise-induced platelet-leukocyte conjugation
  - Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus
  - Platelet function and inflammatory markers in patients with type 1 diabetes with and without microvascular complications
Wallen N. H. - Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
Wallén N. H. - Enhanced platelet and leukocyte activation by strenuous exercise in type I diabetes mellitus
  - Clopidogrel treatment reduces platelet activity in vivo, but does not counteract exercise-induced platelet activation
Wallis D. E. - A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Walsh M. - Studies to define the clinical impact of ‘mild’ hemophilia A in a large kindred in Newfoundland and Labrador
Walsh G. - Functional modulation of platelet aIIbb3 by its endogenous thiol isomerase activity
Walsh P. N. - Thrombin-induced platelet signaling results in factor IXa binding to a subpopulation of platelets with low or absent GP1b antigen
Walsh P. N. - Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells
Walsh P. N. - Association of factor X with lipid rafts in the presence of active cofactor (factor VIIIa) promotes the assembly of factor-X activating complex on the activated platelet membrane
  - Binding to a negatively charged surface alters the conformation of factor XIa
Walsh P.N. - Factor XI-activation by thrombin on activated platelets requires both anion binding exosites I and II
Walsh M. - An evaluation of existing measurement methods in assessing menstrual blood loss in women with hereditary bleeding disorders
Walsh P. N. - The omega-loop within the Gla domain (G4–Q11) and the EGF2 domain (C88–C124) of factor IXa are both essential for the assembly of the FX activating complex on activated platelets
Walsh P. N. - Identification of a binding site for glycoprotein Iba in the Apple 3 domain of factor XI
Walter U. - Proteoglycans dock kininogens to cells and regulate generate bradykinin generation
Walter O. - Determination of High-Molecular-Weight von Willebrand factor multimers and their impact on specific VWF-activities in VWF/FVIII-concentrates
Walter U. - Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
  - Novel role for the membrane-bound chemokine fractalkine as a pathophysiologically relevant mechanism in platelet activation and adhesion
  - Factor XI: its role in thrombotic disease of patients with factor V Leiden
Walter O. - Comparison of von Willebrand factor activities measured by ristocetin cofactor assay and two different VWF-collagen-binding-assays in VWF/FVIII-concentrates
Walter U. - Inhibition of platelet activation in congestive heart failure by selective aldosterone receptor antagonism and angiotensin-converting enzyme inhibition – role of platelet VASP phosphorylation
Waltham M. - Enhanced thrombus recanalization and resolution after vascular endothelial growth factor (VEGF) naked DNA gene transfer
Walton P. - Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
Walton S. M. - Factors that influence the prescribing of low-molecular-weight heparins (LMWHs) in community hospitals: opinions of physicians, clinical pharmacists, and formulary committee members
Wan J. - Plasma hemostatic markers in patients with malignancy: correlation with tumor progression and response to treatment
  - Plasma markers of hemostatic activation in patients with cancer and deep venous thrombosis
Wander K. - Benefit and risk of heparin addition in maintaining peripheral venous catheters in neonates – a prospective, double-blind, placebo-controlled trial
Wang Z. Y. - The frequency of P475S polymorphism in von Willebrand factor-cleaving protease among Chinese population and its relevance to arterial thrombotic disorders
Wang E. - TAFI is cross-linked by its activation peptide to sites on fibrin(ogen) distinct from other inhibitors of fibrinolysis
Wang Z. - Establishment of urokinase receptor gene antisense RNA transfer system and its influence on uPAR expression in leukemia cells
Wang L. - Quantification of ADP and ATP receptor expression in human platelets
Wang Y. - A recombinant von Willebrand factor fragment inhibits binding of von Willebrand factor to glycoprotein Ib-IX
Wang H. - Identification of amino acids in antiplasmin involved in the noncovalent ‘lysine-binding site’ dependent interaction with plasmin
Wang L. - Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
Wang W. - Quantitative analysis of gene expression for vascular endothelial growth factor and its application
Wang Y. C. - A G-to-A mutation at -33 position in the promoter region of thrombomodulin gene and non-O blood group are associated with idiopathic venous thromboembolism: Taiwan Thrombophilia Study
Wang W. - Identification of two novel point mutations in XIII A chain gene associated with congenital deficiency in a Chinese FXIII deficiency family
Wang P. - Legg-Perthe's disease and thrombophilia: a causal association?
Wang Y. - Activated protein C as a proteolytically activable antioxidant, anticoagulant protein
Wang H. - Triple heterozygosity in the alphaIIb gene of a patient with Glanzmann thrombasthenia and platelets with a low alphaIIbbeta3 content
Wang G. - Expression of prion protein (PrPC) in the megakaryocyte lineage
Wang H. - Reversible inactivation of anti-plasmin: evidence for a latent conformation
Wang Q. Q. - A chimeric anti-human tissue factor antibody attenuates inflammatory responses in rhesus monkeys challenged with E. coli
Wang Y-X. - Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Wang S. J. - Apoptotic effect of cleaved high molecular weight kininogen is selectively regulated by extracellular matrix proteins
Wang L. - Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Wang S. - Incidental pulmonary embolism in patients with cancer
Wang Y. - Peptides from the C-terminal regions of ADAMTS-13 specifically block cleavage of ultra-large von Willebrand factor multimers on the endothelial surface under flow
  - A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Wang Y. X. - Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Wang H. - Procoagulant surface expression on activated human platelets persists despite increased aminophospholipid translocase activity
Wang C. J. - Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
Wang Z. - A novel point mutation in the transmembrane domain of the platelet glycoprotein IX associated with bernard–soulier syndrome
Wang H. - Senescent rabbit platelets, or rabbit platelets with experimentally shortened survival, are apoptotic with increased surface exposure of procoagulant phosphatidylserine (PS)
Wanitkun S. - Successful use of recombinant activated factor VII for controlling bleeding in patients receiving invasive surgeries
Wannamethee G. - Associations of hemostatic and inflammatory variables with prevalent myocardial infarction, angina and stroke in British men: British Regional Heart Study
Ward C. M. - Glycoprotein IX Asn45Ser: an ancestral mutation causing Bernard–Soulier syndrome in Europeans?
Ward C. - Inherited thrombophilias are not increased in ‘idiopathic’ small for gestational age pregnancies
Ward S. A. - Familial segregation of venous thromboembolism
Ward C. M. - A prospective randomized trial of anti-platelet therapies in patients with carotid artery disease (preliminary results)
Ward A. - Factor Xa is profoundly protected from Antithrombin–arixtra and antithrombin-Lovenox when incorporated into the prothrombinase complex
Ware J. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
Ware J. - Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
  - Platelet septins and enhanced platelet function in SEPT5-deficient platelets
Ware J. L. - Convulxin binds to native, human glycoprotein Iba (GPIba)
Ware J. - Regulation of megakaryocyte polyploidization and platelet release by the cytoplasmic tail of glycoprotein Iba
Ware J. - Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
  - Increased shear rate threshold in mouse blood for the dependence of platelet thrombus formation on glycoprotein Iba
Warkentin T. E. - A systematic analysis of the effects of a thrombin-specific inhibitor, argatroban in HIT
Warlow C. - Stroke: killer clots and killer drugs
Warrell D. - Characterization of novel platelet and procoagulant activities from Bothrops cotiara snake venom
Warrington C. M. - Increased VWF antigen clearance in partial quantitative von Willebrand factor deficiency and reporting of a familial tendency
Wasi P. - A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
Wasserman J. - Health-related quality of life in adults with hemophilia: the patient perspective
Watala C. - Platelet resistance to aspirin is associated with increased membrane lipid cholesterol
Watala C. - Time-dependent restoration of effective inhibition of blood platelet function after coronary artery by-pass grafting
Watanabe H. - Effects of argatroban in combination with oral anticoagulation on thrombin generation
  - Transition of treatment with i.v. Argatroban to Phenprocoumon and Acencoumarol
  - Influence of argatroban alone and combined with oral anticoagulants on the assessment of coagulation factors
  - Effects of argatroban alone or in combination with phenprocoumon or acenocoumarol on aPTT and ecarin clotting time
  - Interaction of thrombolytic agents with argatroban: pharmacological implications
Watanabe S. - GTT: A comprehensive in vitro haemostasis test, assessing platelet function, coagulation and thrombolytic activity from a single native blood sample
Waterworth D. M. - Disease genetics and recent advances in pharmacogenetics
Watkins N. A. - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Watkins N. A. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
Watkins N. - The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Watkins N. A. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
Watson M. A. - Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
Watson S. P. - GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Watson P. - Type 2M von Willebrand disease: correlation of phenotype with genotype?
Watson S. P. - Collagen induces tyrosine phosphorylation of signaling proteins in Fc receptor g-chain-deficient platelets
  - A novel pathway of phospholipase Cg2 activation downstream of the platelet integrin aIIbb3
  - PLCg2-independent activation of integrins by GPVI: involvement of PLCg1 and PI3-kinase
  - The peptide LSARLAF causes platelet aggregation through PLCg2 and can induce platelet activation independent of GPIIbIIIa
  - The interaction of von Willebrand factor with GPIba; induces GPIIb-IIIa-dependent secretion
Watson P. - Removing the bottleneck – automated detection of point mutations in the factor VIII gene by fluorescent sequence trace subtraction following high-throughput DNA sequencing
  - Automated DNA sequencing of the essential regions of the FVIII gene for rapid carrier and prenatal diagnosis in hemophilia A
Watson S. P. - Integrin a2b1 stimulates platelet spreading through protein tyrosine phosphorylation and calcium mobilization
Watson S. - Epidermiology and anti-inflammatory mechanism - Epidemiology and pharmacoeconomics
Watson S. P. - Characterization of novel platelet and procoagulant activities from Bothrops cotiara snake venom
  - Variation of GPVI levels in platelets: relationship to platelet function at high shear
Watt G. - Associations of hemostatic and inflammatory variables with obesity and blood pressure in men and women aged 30–59 years: cross-sectional population survey
Watt A. J. - Catheter-related venous thrombosis in children diagnosed by magnetic resonance venography
Watt G. H. - Coagulation and endothelium activation in patients with scrub typhus
Watt G. - Effects of age, sex, and oral contraceptive use on hemostatic, fibrinolytic and inflammatory variables: cross-sectional population survey
Wattam B. - The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Watzka M. - Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
  - Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Watzke H. - The impact of interassay-variations in the International Normalized Ratio on dosing oral anti-coagulants
Wautier M. P. - Glycoxidation products and S100 calgranulin binding to RAGE induce tissue factor production
Wautier J. L. - Glycoxidation products and S100 calgranulin binding to RAGE induce tissue factor production
Wautier M. P. - Erythrocytes from diabetic patients adhere to endothelium and potentiate leukocyte adhesion molecule expression
Wautier J. L. - Erythrocytes from diabetic patients adhere to endothelium and potentiate leukocyte adhesion molecule expression
Wautier J. L. - Erythrocytes bearing (carboxymethyl)lysine bind to endothelial RAGE and alter vascular permeability in diabetic rats
Wautier M. P. - Erythrocytes bearing (carboxymethyl)lysine bind to endothelial RAGE and alter vascular permeability in diabetic rats
Wautrecht J. C. - Phenotype of T cells in human abdominal aortic aneurysm
Weaver D. - An in silico analysis of type 2 A von Willebrand disease mutations
Weaver C. - The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leukocyte function in healthy subjects and patients with previous ischemic stroke
Webb B. A. - A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) assembly
Webb R. L. - Platelet inhibition by valsartan and valeryl 4-hydroxy valsartan: a possible missing link to explain benefits of angiotensin II receptor blockers in patients after acute vascular events
Weber L. C. - Recombinant FVIIa promotes adhesion and aggregation of platelets in normal subjects and von Willebrand disease patients as measured in the PFA100™
Weber S. - Human platelet microparticles shedding is independent of the Cdc42/Rac1/PAK Pathway
Weber A. - Analytical comparison of recombinant and plasma-derived activated protein C (APC)
Webster S. - The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
Webster B. H. - Warfarin-induced skin necrosis in a child with protein C deficiency and Factor V Leiden mutation
Webster S. - Treatment of severe canine hemophilia A by helper-dependent adenoviral-mediated gene therapy
Weerheim A. M. - Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin layer chromatography
Wegert W. - Using a modified thrombin generation assay for potency assessment of B-domain deleted recombinant factor VIII (ReFacto®)
Wegert W. - Thrombin generation in platelet-rich plasma (PRP) is enhanced in patients with metabolic syndrome
Wehling J. - Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
Weibert R. - The effect of dietary vitamin K1 on warfarin maintenance dose requirements
Weidinger G. - Prevention of venous thromboembolism in orthopedic trauma patients receiving heparin thromboprophylaxis – a substudy analysis of autopsy-confirmed fatal pulmonary embolism
  - Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
  - Combined analysis of 2 studies on the clinical outcome over 6 months in patients with symptomatic acute deep vein thrombosis initially treated with one low-molecular-weight heparin
Weigand B. - Tissue factor stimulates migration by activation of the mitogen-activated proteinkinase p38 and the GTPase Rac1
Weigel G. - Biochemical fibrinogen modification and atherogenesis
Weijer S. - Plasminogen activator inhibitor type I-deficient (PAI–/–) mice show an improved early host defense in E. coli peritonitis by a neutrophil-dependent mechanism
Weijer S. - Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
  - Coagulation factor profiles respond strongly during human endotoxemia
Weiler H. M. - Gene array transcript profiling of human endothelial cells identifies pathways regulated by Drotregocin alfa (activated)
Weiler H. - Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
  - Platelets and fibrinogen are not required for embryonic development but have distinct roles for placentation
Weiler H. - Biological and pathological roles of thrombomodulin
Weiler H. M. - Drotrecogin alfa (activated) inhibits degradation of cytokine-mRNA in an endothelial model of inflammation
Weiler H. - Altered vascular remodeling in hyperfibrinogenemic mice
Weimer T. - Limiting the parvovirus B19 load in manufacturing pools results in final containers of plasma derivatives nonreactive for parvovirus B19 genome
Weinreb G. E. - Efficient human thrombin generation requires molecular phosphatidylserine and not a membrane surface
Weinreb G. E. - Water soluble phosphatidylserine (C6PS) induces bovine factor Xa structural change and dimerization; do factor Xa dimers have a physiological role?
Weinstock N. - ATIII substitution. Are all products the same
  - Risk factors. Fibrinogen vs. Lipoproteins: a new view
Weippert-Kretschmer M. - Evaluation of an automated von Willebrand factor (vWF) antigen assay
Weir E. K. - Experimental studies of anorectic drug cardiovascular toxicity: oral fenfluramine decreases dog platelet serotonin uptake and content, elevates plasma serotonin and causes mild mitral valve regurgitation
Weirich U. - Construction and characterization of a new recombinant plasminogen activator composed of an antifibrin single-chain antibody and a low molecular weight form single-chain urokinase
Weisel J. W. - The effect of factor XIII Val34Leu on clot structure is fibrinogen dependent: evidence for a mechanism for cardioprotection of the Leu allele at high fibrinogen levels
Weisel J. - Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Weisel J. W. - Intermolecular forces of individual aIIbb3-fibrinogen and aVb3–osteopontin interactions on platelets
  - Bb448 Lys/Lys variant alters coronary risk by an effect on fibrin structure/function due to conformational changes in fibrinogen
  - Cross-linking of fibrin by factor XIII and its effect on fibrin structure/function
  - A monoclonal antibody to the fibrinogen g chain alters clot structure and properties by producing thinner fibrin fibers arranged in bundles
  - aIIbb3 integrin activation mechanisms – switchblade or scissors?
Weiss D. - Prophylactic warfarin in clinical practice. Treatment intensity when warfarin is used to prevent VTE after major joint surgery: findings from the Global Orthopedic Registry (GLORY)
Weissmann M.D. - Human blood platelets: RNA transcript profiling using microarray and serial analysis of gene expression
Weitz J. - GH9001, a novel anti-thrombotic agent, is more effective than low-molecular-weight heparin, fondaparinux, or hirudin in rabbit models
Weitz J. - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
  - Prognostic value of activated protein C levels in patients with severe sepsis
  - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Weitz J. I. - gA/g' fibrin affords thrombin greater protection from inhibition by the heparin/antithrombin complex than gA/gA fibrin
Weitz J. - New oral anticoagulants
Weitz J. I. - Paradoxical effect of unfractionated heparin in combination with streptokinase on arterial recanalization
Welch K. M. - Inhibition of human prothrombinase by PD0313052 reveals advantages of active site-directed factor Xa inhibition
Weller L. J. - Estimation of von Willebrand factor: collagen binding in therapeutic concentrates
Wells P. S. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Wells D. J. - Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
Wells P. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
  - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
  - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Weltermann A. - Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
Weltermann A. - The effect of pretreatment with clopidogrel on platelet and coagulation activation in patients with stable angina undergoing elective coronary stenting
Weltermann A. - The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
Wen J. H. - Protection of a chimeric antihuman tissue factor monoclonal antibody against tissue factor-induced acute thrombosis in mice
Wen Z. B. - Influence of tetramethylpyrazine on the expression of tissue factor induced by proinflammatory cytokines in endothelial cells
Wen Z. B. - Mechanisms for angiotensin II on tissue factor expression in human peripheral blood monocytes
  - Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes
Wen J. H. - Anti-metastatic effect of an anti-human tissue factor monoclonal antibody on human breast and prostate experimental metastasis models in nude mice
Wen Z. B. - Effects of adrenaline and noradrenaline on the expression of tissue factor in endothelial cells
Wen C. Y. - Hemophilia as a model for analysis of human germ-line mutagenesis: frequent mosacism and low male to female sex ratio for G:C®A:T nonCpG transitions and the first observation of a nucleotide bi-mutation are consistent with effects in early embryogenesis
Wen Z. B. - Determinations of plasma protein C activity and antigen levels in patients with liver diseases and its clinical significance
Wencel-Drake J. D. - Effect of cellular and receptor activation on the extent of integrin alphaIIb beta3 internalization
Wenning B. - Risk factors and long-term follow-up of patients with the immune type of heparin induced thrombocytopenia
  - Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia
Wensheng L. - Observation of preventive and therapeutic effects of anti-thrombin-III on experimental disseminated intravascular coagulation
  - A study on the changes in of plasma coagulative, anti-coagulative, fibrinolytic activities in patients with cerebral infarction and the therapy with low molecular weight heparin
Wenzel E. - Sensitivity of platelet retention test Homburg (RTH) in drug monitoring and measuring vs. Willebrand factor–mediated platelet adhesiveness
Werms C. - Sensitivity of platelet retention test Homburg (RTH) in drug monitoring and measuring vs. Willebrand factor–mediated platelet adhesiveness
Wernhart W. - Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Wesenberg F. - Family history of thromboembolism does not identify children with thrombophilia – A cross-sectional study
Westein E. - LDL-receptor related protein (LRP) interacts with leukocyte integrin CD11b/CD18: a novel pathway in inflammatory regulation?
  - An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
Westendorp R. G. - A functional single-nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) associated with risk and outcome of meningococcal disease (MD)
Wester J. P. J. - Lepirudin anti-coagulation in critically ill patients with (suspected) heparin-induced thrombocytopenia and thrombosis
Western A. - Profile of mutations in a UK hemophilia A patient population
Westfield L. A. - Dominant negative anticoagulant effects of mouse recombinant meizothrombin precursor R157A/R268A delay thrombus formation in a mouse injured carotid artery
Westmuckett A. D. - Cholesterol and caveolin modulate the cell surface distribution and activity of TFPI
Weston S. B. - Optimization of factor VIII clotting assays: evaluation of VWF content in FVIII-deficient plasma and effect of albumin in dilution buffer
Westrick R. J. - A sensitized ENU mutagenesis screen for dominant genetic modifiers of thrombosis in the factor V Leiden mouse
  - The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function
Westrup D. - Electron microscopy of thrombasthenic platelets after rFVIIa substitution
Wettstein P. - Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
Wetzel N. - A case of compound type 2N/type 1 von Willebrand disease linked to a novel von Willebrand factor exon 18 mutation A2311G encoding for Met 771 val
Wetzel N. P. - Assay of the von Willebrand factor propeptide in patients with type 1 von Willebrand disease (VWD) and the identification of patients with a S2179F mutation in the D4 region of von Willebrand factor
Wetzel N. - Type 2 M von Willebrand disease due to linked P1266Q and V1279I substitutions in the von Willebrand factor A1 domain
Wheeler M. L. - Secondary thromboprophylaxis program assessing the efficacy of mini dose warfarin and prothrombin fragment 1 + 2 in selected high risk patients with venous thromboembolism
Wheeler M. - Laboratory diagnosis of congenital thrombophilia: current and past practice in Australia
Whincup P. H. - Associations of hemostatic and inflammatory variables with prevalent myocardial infarction, angina and stroke in British men: British Regional Heart Study
Whinna H. C. - Role of surface amino acid residues in thrombin essential for inhibition by antithrombin, heparin cofactor II and protein C inhibitor
  - Effect of a RNA-thrombin aptamer on thrombin inhibition by antithrombin, heparin cofactor II and protein C inhibitor
White M. M. - Evaluation of the point of care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for assessment of platelet function inhibition by platelet GPIIb-IIIa antagonists
White G. C. - Mutation analysis and HLA genotype in patients with inhibitors and hemophilia A
  - Bleeding phenotype and decreased viability in rap1b knockout mice
White R. - The epidemiology of venous thromboembolism in California
  - Effect of age on the incidence of venous thromboembolism after surgery
White K. - Concomitant use of mechanical and pharmacological methods of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: Findings from the Global Orthopaedic Registry (GLORY)
White R. - Incidental pulmonary embolism in patients with cancer
White A. E. W. - The mechanism of platelet aggregation in whole blood in response to adenosine triphosphate: involvement of neutrophil ecto-ATPase activity and adenosine
White J. G. - Stored platelets contain residual amounts of tissue factor
White K. - Prophylactic warfarin in clinical practice. Treatment intensity when warfarin is used to prevent VTE after major joint surgery: findings from the Global Orthopedic Registry (GLORY)
White G. C. - Lineage-specific correction of a hemorrhagic disorder affecting platelets: gene therapy for Glanzmann thrombasthenia
White II G. C. - Current concentrates: how much better can they get?
White III G. C. - Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Whiteheart S. W. - Translocation of plasma membrane Ca2+-ATPase to filopodia during platelet activation
Whitsett C. - Relationship of the Val34Leu polymorphism in the factor XIII gene with venous thromboembolism in American whites and blacks: the GATE study
  - The relationship between genetic variants in peroxisome proliferator-activated receptors and venous thromboembolism in African-Americans and Caucasians
Whittier A. - Increased thrombin–anti-thrombin III levels in pre-eclampsia and disseminated intravascular coagulation
Whitton C. M. - A survey of streptokinase products shows inconsistencies in the quality of thrombolytic products used worldwide
  - In vitro studies and computer simulations of plasminogen activation kinetics in fibrin clots
Wice S. M. - The effect of orally administered heparins on a rat carotid arterial model of thrombosis
Wick G. - Some aspects of human immunity against heat shock proteins 60/65
Wiedermann C. J. - Eosinophils as a novel target for protein C
  - Expression of endothelial protein C receptor by human neutrophils and its role in cell migration
Wieding J. U. - Sensitivity of platelet retention test Homburg (RTH) in drug monitoring and measuring vs. Willebrand factor–mediated platelet adhesiveness
Wiegand G. - Laborious way to an efficient prophylaxis: Homozygous prothrombin G20210A mutation in a neonate with cardiac diverticulum
Wiegand G. - Non-catheter related pulmonary artery thrombosis in a premature
Wielckens K. - Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Wielders S. - Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
Wiemer M. - Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
  - The G allele of IL-6–174G/C polymorphism is a risk factor for restenosis after coronary stent implantation by increased inflammation and platelet activation
Wiesenburg A. - PADA – fast and quantitative monitoring of blood platelet adhesiveness
  - PADA-HIT: A new POCT method for ultra-fast detection of HIT II antibodies
Wihlborg A. K. - Quantification of ADP and ATP receptor expression in human platelets
Wijns W. - The clinical relevance of anti-b2-GP1 antibodies assays in the presence of antiphospholipid antibodies and/or lupus anticoagulant
Wikström P. - A rapid chromogenic method for determination of TAFI in plasma samples
Wilbourn B. R. - The mechanism of platelet activation by recombinant factor VIIa in normal subjects and inherited hemostatic disorders – a whole blood, flow cytometric study
  - Whole blood thromboelastography and platelet function studies with DX-88, a Kunitz-type inhibitor of kallikrein
Wilcox D. - A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Wilcox J. - Regulation of coagulation factor VII expression in dermal fibroblasts by serum and growth factors
Wilcox D. A. - Lineage-specific correction of a hemorrhagic disorder affecting platelets: gene therapy for Glanzmann thrombasthenia
Wilcox J. - Extrahepatic synthesis of coagulation factor VII in prostate and breast cancer
Wilde J. T. - Identification of six novel mutations in families with type 3 von Willebrand disease
Wilde J. I. - GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Wilde J. T. - Are there really undetectable Factor VIII mutations in hemophilia A? How can we deal with the difficult ones?
Wildgoose P. - Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
  - Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with prolonged periods of immobilisation: the EXCLAIM study
Wilhelm C. - Expression of Plasminogen activator inhibitor-1 (PAI-1) mRNA in human ciliary processes and determination of PAI-1 in human aqueous humor
Wilhelm S. E. - Investigation of residues in the fibrin(ogen) gamma chain involved in t-PA binding and plasminogen activation
Wilhelm C. - New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
Wilhelm C. - A mutation leading to a stop codon in the FVIII gene is the cause of severe canine Hemophilia A
Wilhelm M. - cGMP regulates thrombopoietin-induced CD34+ human stem cell proliferation and differentiation into megakaryocytes
Wilhite D. - Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Wilker P. R. - Drug-dependent antibodies are accompanied by drug-specific antibodies in Quinine-induced immune mediated thrombocytopenia
Wilker P. W. - Drug-dependent antibodies, what binds where?
Wilkes M. M. - Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis – a meta-analysis
Wille-Jørgensen P. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Wille-Jorgensen P. - Prolonged thromboprophylaxis with low molecular weight heparin (tinzaparin) following major general surgery primarily for cancer: An individual patient data meta-analysis
Willems H. P. J. - Homocysteine lowering by B vitamins and the prevention of secondary deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Willems G. - IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
Willemse J. - An evaluation of 30 years of hemophilia treatment in the Netherlands
  - Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
Willen D. R. - The high frequency and specificity of the Lupus cofactor effect in a dPT screen
Williams J. T. - Novel family based approaches to genetic risk in thrombosis
Williams J. - An interactive coagulation laboratory database benefiting the entire Hemophilia Center team
Williams I. J. - Are there really undetectable Factor VIII mutations in hemophilia A? How can we deal with the difficult ones?
Williams M. D. - Are there really undetectable Factor VIII mutations in hemophilia A? How can we deal with the difficult ones?
Williams C. E. - Two candidate type 2 M von Willebrand disease mutations in two unrelated families with unusual phenotypes
Williams M. D. - Two candidate type 2 M von Willebrand disease mutations in two unrelated families with unusual phenotypes
Williams A. - Whole blood thromboelastography and platelet function studies with DX-88, a Kunitz-type inhibitor of kallikrein
Williams M. D. - Compound heterozygous Protein C deficiency resulting in neonatal purpura fulminans: identification of a novel mutation and its functional consequences
Williams S. - Vena cava filters in children: review of a single centre clinical experience over 7 years
Williams W. - Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
Williams M. - Prophylactic factor replacement therapy in children with severe factor X deficiency
Williams A. - A novel r-polypeptide, kunitz-type inhibitor with high specificity for plasma kallikrein and potential for therapeutic use
Williams L. - Isolated sustained elevated antib2 Glycoprotein 1 antibodies: association with primary anti-phospholipid syndrome and thrombotic events
Williamson R. C. N. - Low-molecular weight heparin therapy and survival in patients with malignant disease
Williamson L. M. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
Wilmer M. - A rapid chromogenic method for determination of TAFI in plasma samples
Wilmer M. - Factor V Leiden mutation (FV:Q506): A new functional screening assay with 100% specificity and sensitivity
Wilmott R. - Fatal pulmonary embolism in medical patients
  - Thromboprophylaxis in medical patients: national survey of consultant physicians in the United Kingdom
Wilson S. W. - Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Wilson J. M. - Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Wilson K. M. - Effect of mechanical ventilation on carotid artery thrombosis induced by photochemical injury in mice
Wilson E. - Loss of tolerance for platelet glycoprotein VI by vaccination of Balb/c mice with a GPVI-tetanus toxoid fusion protein
Wilson S. - The effect of ABO and Secretor genotypes on thrombin generation
Wilson E. - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Wilson E. - The effect of low and high dose aspirin on the expression of monocyte tissue factor
Wilson E. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
Wiman B. - The t-PA/PAI-1 complex in plasma in relation to risk of myocardial infarction as evaluated in the Stockholm heart epidemiological program (SHEEP)
  - Prospective evaluation of t-PA/PAI-1 complex predicting myocardial infarction in controls included in the SHEEP study
  - Identification of amino acids in antiplasmin involved in the noncovalent ‘lysine-binding site’ dependent interaction with plasmin
  - Reversible inactivation of anti-plasmin: evidence for a latent conformation
Wimmel A. - Coagulation factor V in normal bronchial epithelial and lung cancer cells
Wimperis J. - Management of pulmonary embolism: Can we consider outpatient treatment?
Winckler J. - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Windyga J. - Lupus anticoagulant and elevated anticardiolipin antibodies as risk factors for venous thromboembolism
Winship P. R. - The human protein C gene promoter is regulated by androgenic but not oestrogenic factors
Winter M. - Urokinase induced fibrinolysis in thromboelastography (UKIFTEG): a new assay for determining fibrinolysis in whole blood
Winter P. C. - Fibrinogen gene mutations causing dysfibrinogenemia are associated with variable phenotypes
Winter M. - Advoy – a useful clinical tool in the management of the patient with hemophilia on home therapy
  - Contact system activation, FXIIa and plasma kallikrein produce enhanced fibrinolysis in urokinase induced fibrinolysis in thromboelastography: (UKIFTEG)
  - Preparations of beta-2 glycoprotein I contain plasma kallikrein
Wirmer S. - The impact of factor V Leiden on the endothelial cytokine response to coagulation activation modulated by drotrecogin alfa (activated)
Wisniewska J. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Wisnivesky J. - Perioperative management of patients on oral anti-coagulants: a decision-analysis
Witteman J. C. M. - Genetic variability of von Willebrand factor and coronary heart disease: the Rotterdam Study
  - Association between genetic variability of von Willebrand factor and peripheral atherosclerosis: the Rotterdam Study
Wittevrongel C. - Functional polymorphisms in the paternally expressed XLas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation resulting in platelet Gs hyperfunction
  - The Gs agonist PACAP(1–38) is a physiological inhibitor of platelet aggregation and megakaryocyte maturation
Wittkowsky A. K. - Clinical outcomes and medical resource utilization in patients with and without malignancy treated with warfarin
Wodnicka M. B. - Bleeding phenotype and decreased viability in rap1b knockout mice
Wolberg A. S. - A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function
  - The effect of temperature and pH on the activity of FVIIa: implications for the efficacy of high-dose FVIIa in hypothermic and acidotic patients
Wolberg A.S. - Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Wolczynski S. - Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Wolf H. - Prevention of venous thromboembolism in orthopedic trauma patients receiving heparin thromboprophylaxis – a substudy analysis of autopsy-confirmed fatal pulmonary embolism
Wolf H. H. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Wolff R. - Venous thrombosis in cancer patients: insights from the FRONTLINE survey
Wollersheim H. - Compression bandaging in the acute phase of deep-vein thrombosis reduces symptoms but does not decrease venous outflow resistance and thrombosisscore as a proxy of the post-trombotic syndrome
  - Venous outflow resistance can be used after acute deep-vein thrombosis as a screening test to identify patients at risk of the post-trombotic syndrome
  - IL-6 concentration in the acute phase of deep-vein thrombosis is a strong predictor of elevated venous outflow resistance as a proxy of post-trombotic syndrome
Wolosker N. - Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Wolz W. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Wonerow P. - A novel pathway of phospholipase Cg2 activation downstream of the platelet integrin aIIbb3
Wonerow P. - The peptide LSARLAF causes platelet aggregation through PLCg2 and can induce platelet activation independent of GPIIbIIIa
  - Involvement of the p110d catalytic subunit of phosphatidylinositol 3-kinase in platelet spreading on fibrinogen
Wong L. - Critical lower limb ischemia caused by essential thrombocytosis and successful limb salvage using angiographic-guided intra-arterial thrombolysis with rTPA
Wong H. C. - A chimeric anti-human tissue factor antibody attenuates inflammatory responses in rhesus monkeys challenged with E. coli
  - Protection of a chimeric antihuman tissue factor monoclonal antibody against tissue factor-induced acute thrombosis in mice
Wong J. - Venous thrombosis in cancer patients: insights from the FRONTLINE survey
Wong H. C. - Anti-metastatic effect of an anti-human tissue factor monoclonal antibody on human breast and prostate experimental metastasis models in nude mice
Wong J. - Use of umbilical cord vein in an in vitro perfusion model to study blood-borne metastasis
Wong T. - Differential use of variable domains of D3H44 antibody in binding to tissue factor or to an anti-idiotypic antibody
Wongchanchailert M. - The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome
Wood P. - Point-of-care testing shows clinically relevant variation in the degree of inhibition of platelets by standard dose abciximab therapy during percutaneous coronary intervention
Wood T. - Use of umbilical cord vein in an in vitro perfusion model to study blood-borne metastasis
Woodfield D. G. - Geographic distribution of asymptomatic constitutional macro thrombocytopenia in Indian subcontinent
Woodhams B. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
  - A modified ELISA procedure for platelet factor 4 with decreased heparin sensitivity
Woodhams B. J. - Normal values of total and free TFPI levels in the newborn and in children
Woods T. A. L. - Von Willebrand factor measurement in the UK NEQAS proficiency testing program
Woods T. A. L. - Use of SSC/ISTH secondary standard to evaluate laboratory performance: A UK NEQAS for blood coagulation proficiency testing exercise
Woods A. I. - Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
Woods T. - An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Woods T. A. L. - Artificially depleted plasmas are suitable for proficiency testing of INR determination with some POC devices
Woods A. I. - Comparative study of conformation sensitive gel electrophoresis and DNA sequencing for polymorphisms and mutation detection in von Willebrand disease type 2 N
  - Platelet von Willebrand factor antigen (VWF:Ag-i) in patients with mucocutaneous bleeding tendency and normal von Willebrand factor (VWF) plasma levels
Woods A. - Incidence of major hemorrhages related to surgery in type 1 von Willebrand's disease patients
Woods T. A. L. - Accuracy of laboratory diagnosis of familial thrombophilia, 2001–2002: UK NEQAS experience
  - Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing program
Woods K. - Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Woods T. A. L. - SSC classification of hemophilia A: is it achievable? A UKNEQAS supplementary exercise
  - Diagnosis of factor XIII deficiency – room for improvement? Experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
  - Results of d-dimer in the UK NEQAS (Blood Coagulation) proficiency testing program: Urgent need for improvements in Standardization of testing and reporting
  - Possible causes of variation in INR results in UK NEQAS EQA program for Near Patient Testing/Point of Care devices
Woodward M. - Is homocysteine an independent risk factor for myocardial infarction? Results from the Glasgow myocardial infarction study
Woolley A. M. - Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Woolley A. M. - ROTEG thromboelastography: sample stability and results in warfarinized and heparinized patients
Woram R. A. - Identification of the multimerin binding region within the C2 domain of human factor V using constructs generated by alanine scanning and site-directed mutagenesis
Worsley A. - Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Woulfe D. - Contact-dependant signalling during late events of platelet activation
Woznica D. V. - Activation of platelets by HIT antibodies in vitro is not dependent on the presence of heparin
Wozniczko D. - Anti-thrombotic treatment after coronary artery bypass graft surgery (CABGS):economic consequence of a change in regimen
Wright D. - A prospective study examining the effect of a two milligram dose of oral Konakion given to patients with an INR > 8
Wright C. E. - Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
Wright J. R. - Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Wróblewska M. - Thrombophilic risk factors of ischemic stroke in children
Wrona L. - Argatroban anticoagulation inhibits thrombin generation and its rebound during percutaneous interventional procedures
Wu Q. - Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Wu F. - Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Wu Y. - Differential role of phosphatidylinositol 3-kinase in glycoprotein Ib-mediated platelet activation
Wu Y-P. - Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Wu O. - Screening for thrombophilia: an economic assessment
Wu O. - Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
Wu J. - Increased fibronectin secretion but not cell surface expression in thrombin-activated platelets of hypofibrinogenemia patients
Wu C. M. - Modulation of thrombin signaling by internalization of thrombin and thrombomodulin complex
Wu H. L. - Modulation of thrombin signaling by internalization of thrombin and thrombomodulin complex
Wu W. B. - Gramicetin: a new agonist that activates platelets via glycoprotein Ib ligation
Wu K. K. - Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
Wu C. - Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Wu Q. - Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Wu F. C. - Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Wu Y. - Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
Wu J. K. - Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
  - Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Wu O. - The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
WU X.-X - Annexin A5 resistance in the antiphospholipid (aPL) syndrome
Wu H. - Proteomic identification of tissue factor regulatory components in blood monocytes
Wu H. L. - Enhanced anti-angiogenesis ability of human kringle 1–5 domain via altering glycosylation sites and lysine binding properties
Wu J. K. - An assessment of the appropriateness of published pediatric dosage guidelines for low molecular weight heparin (Enoxaparin) in a tertiary care institution
Wu J. K. - Pre-surgical reversal of warfarin using recombinant activated factor VII (rFVIIa) in a pediatric patient with prosthetic heart valves
Wulff K. - Molecular genetic analysis of gene variants in the 5' flanking region of the FVII gene: Identification of a novel mutation in a German family
Wulff K. - Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Wulff K. - Molecular genetic analysis in the factor X gene in patients with congenital FX deficiency
Wun T. - Incidental pulmonary embolism in patients with cancer
Wyczolkowska J. - Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
Wysokinski W. E. - Risk of recurrence of cerebral venous and sinus thrombosis, influence of treatment
  - Plasmin-alpha2–anti-plasmin complex in diabetic and non diabetic patients with peripheral arterial occlusive disease
  - Cerebral venous sinus thrombosis. The spectrum of risk associated with this unique thrombotic disorder